Radiotherapy is the standard of care treatment for unresectable NSCLC, combined with
concurrent chemotherapy and adjuvant immunotherapy. Despite technological advances in …

Delineation of cardiac substructures is crucial for a better understanding of radiation‐related
cardiotoxicities and to facilitate accurate and precise cardiac dose calculation for develo** …

Background Arrhythmias are common following radiotherapy for non–small cell lung cancer.
Objectives The aim of this study was to analyze the association of distinct arrhythmia classes …

Normal tissue tolerance dose limits to the heart have been established to reduce the risk of
radiation‐induced cardiac disease (RICD). Dose constraints have been developed based …

Radiotherapy is an essential part of treatment for many patients with thoracic cancers.
However, proximity of the heart to tumour targets can lead to cardiac side effects, with …

Cardiac risk mitigation is a major priority in improving outcomes for cancer survivors as
advances in cancer screening and treatments continue to decrease cancer mortality. More …

During the proofing process for this article, the authors requested that the rows in Table 1 be
sorted by the number present in Column A 'Author and YearL; this was overlooked by the …

Background Atrial fibrillation (AF) has been associated with thoracic radiotherapy, but the
specific risk with irradiating different cardiac substructures remains unknown. Objectives …

Background Lung cancer is a leading cause of cancer mortality and may require high-dose
thoracic radiation therapy (RT). However, RT significantly increases the risk of radiation …

Radiation therapy (RT), combined with chemotherapy and adjuvant immunotherapy,
remains the standard treatment for unresectable non–small cell lung cancer (NSCLC). 1 …